Literature DB >> 21402900

Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death.

Jonas J Neher1, Urte Neniskyte, Jing-Wei Zhao, Anna Bal-Price, Aviva M Tolkovsky, Guy C Brown.   

Abstract

It is well-known that dead and dying neurons are quickly removed through phagocytosis by the brain's macrophages, the microglia. Therefore, neuronal loss during brain inflammation has always been assumed to be due to phagocytosis of neurons subsequent to their apoptotic or necrotic death. However, we report in this article that under inflammatory conditions in primary rat cultures of neurons and glia, phagocytosis actively induces neuronal death. Specifically, two inflammatory bacterial ligands, lipoteichoic acid or LPS (agonists of glial TLR2 and TLR4, respectively), stimulated microglial proliferation, phagocytic activity, and engulfment of ∼30% of neurons within 3 d. Phagocytosis of neurons was dependent on the microglial release of soluble mediators (and peroxynitrite in particular), which induced neuronal exposure of the eat-me signal phosphatidylserine (PS). Surprisingly, however, eat-me signaling was reversible, so that blocking any step in a phagocytic pathway consisting of PS exposure, the PS-binding protein milk fat globule epidermal growth factor-8, and its microglial vitronectin receptor was sufficient to rescue up to 90% of neurons without reducing inflammation. Hence, our data indicate a novel form of inflammatory neurodegeneration, where inflammation can cause eat-me signal exposure by otherwise viable neurons, leading to their death through phagocytosis. Thus, blocking phagocytosis may prevent some forms of inflammatory neurodegeneration, and therefore might be beneficial during brain infection, trauma, ischemia, neurodegeneration, and aging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402900     DOI: 10.4049/jimmunol.1003600

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  156 in total

Review 1.  A decade of diverse microglial-neuronal physical interactions in the brain (2008-2018).

Authors:  Joseph O Uweru; Ukpong B Eyo
Journal:  Neurosci Lett       Date:  2019-01-06       Impact factor: 3.046

2.  Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study.

Authors:  Alok K Sharma; Nandini Gokulchandran; Pooja P Kulkarni; Hemangi M Sane; Ridhima Sharma; Alitta Jose; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2020-12-25

3.  Microglia and neurogenesis in the epileptic dentate gyrus.

Authors:  Cong Luo; Yuji Ikegaya; Ryuta Koyama
Journal:  Neurogenesis (Austin)       Date:  2016-09-26

4.  Assessing Retinal Microglial Phagocytic Function In Vivo Using a Flow Cytometry-based Assay.

Authors:  Salome Murinello; Stacey K Moreno; Matthew S Macauley; Susumu Sakimoto; Peter D Westenskow; Martin Friedlander
Journal:  J Vis Exp       Date:  2016-10-18       Impact factor: 1.355

5.  Ganglioside accumulation in activated glia in the developing brain: comparison between WT and GalNAcT KO mice.

Authors:  Mariko Saito; Gusheng Wu; Maria Hui; Kurt Masiello; Kostantin Dobrenis; Robert W Ledeen; Mitsuo Saito
Journal:  J Lipid Res       Date:  2015-06-10       Impact factor: 5.922

6.  Draper acts through the JNK pathway to control synchronous engulfment of dying germline cells by follicular epithelial cells.

Authors:  Jon Iker Etchegaray; Allison K Timmons; Adam P Klein; Tracy L Pritchett; Elaine Welch; Tracy L Meehan; Christy Li; Kimberly McCall
Journal:  Development       Date:  2012-09-19       Impact factor: 6.868

7.  Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain.

Authors:  Devon S Svoboda; M Inmaculada Barrasa; Jian Shu; Rosalie Rietjens; Shupei Zhang; Maya Mitalipova; Peter Berube; Dongdong Fu; Leonard D Shultz; George W Bell; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

8.  Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia.

Authors:  Sarah R Anderson; Jianmin Zhang; Michael R Steele; Cesar O Romero; Amanda G Kautzman; Dorothy P Schafer; Monica L Vetter
Journal:  J Neurosci       Date:  2019-01-15       Impact factor: 6.167

Review 9.  Immunopathology of multiple sclerosis.

Authors:  Calliope A Dendrou; Lars Fugger; Manuel A Friese
Journal:  Nat Rev Immunol       Date:  2015-08-07       Impact factor: 53.106

10.  Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma.

Authors:  Elisa R Zanier; Francesca Pischiutta; Loredana Riganti; Federica Marchesi; Elena Turola; Stefano Fumagalli; Carlo Perego; Emanuela Parotto; Paola Vinci; Pietro Veglianese; Giovanna D'Amico; Claudia Verderio; Maria-Grazia De Simoni
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.